# Daily Report — Wednesday, 2026-09-09 — **BOTH BOOKS**

*Agentic account (••••7339, `limited_margin` / `option_level_3`). Written at 14:16 CT / 19:16 UTC by the first run at or after the report window — in-session, 44 minutes before the bell. All quotes stamped 19:16Z. Prompt v10.*

Broker-reconciled at 19:16Z: **1 option + 3 equities, zero drift** on quantity *and* average price. `get_option_orders` for 2026-09-09 is empty; `get_equity_orders` returns exactly one order — this desk's own MDLZ sell — so nothing unauthorized landed and no sibling run placed anything across today's runs.

**Headline: one action today — MDLZ was sold in full at 18:21Z for −$4.07, two days ahead of its time stop, into the best print of its entire 12-day hold.** No entry was taken in either book. The equity slot that exit opened is genuinely free and was declined on merit, not capacity.

---

## 1. Positions

### Equity swing book — 3 open (target 3-4, band 3-5)

| Name | Entry (date) | Shares | Mark 19:16Z | P/L | % | Day | Held | **Time stop** | Why we own it |
|---|---|---|---|---|---|---|---|---|---|
| **LLY** | 1189.7553 (08-27) | 0.420254 | 1125.745 | −$26.90 | −5.38% | **+0.16%** | 13 of 14 | **2026-09-10 (Thu)** | Connors RSI(2) mean-reversion inside a rising 200-day uptrend. Thesis researched **intact** 09-08 — the incretin franchise (orforglipron / tirzepatide / retatrutide) is unbroken. The only book name green today. |
| **MMM** | 173.3371 (08-31) | 2.884552 | 164.69 | −$24.94 | −4.99% | −1.69% | 9 of 14 | **2026-09-14 (Mon)** | RSI(2) dip in an industrial with an intact margin-recovery story. Still prints RSI2 1.8 on today's screen — the setup has deepened, not resolved. |
| **GD** | 374.4437 (09-01) | 1.335314 | 352.8301 | −$28.86 | −5.77% | −1.05% | 8 of 14 | **2026-09-15 (Tue)** | RSI(2) dip in defense. Thesis **re-confirmed INTACT today** — see §2. |

**Equity book: $1,500.00 cost → $1,419.29 mark, −$80.70 unrealized (−5.38%).** All three red, which is the structural reason no take-profit could fire (below).

### Options book — 1 open (the hedge)

| Contract | Entry | Mark 19:16Z | P/L | DTE | Status |
|---|---|---|---|---|---|
| **SPY 2026-11-20 700P ×1** | $749.00 (08-06) | 5.35 → **$535.00** | **−$214.00 (−28.6%)** | 72 | Authorized defensive hedge. **EXEMPT from all premium backstops** — it is insurance, expected to decay in a rising tape. Roll/close decision with Ryan at ~21 DTE (≈2026-10-30). Delta −0.143, theta −$9.80/day, IV 20.7%. Up $31 today on the soft tape. |

No TACTICAL and no CORE position is open. Options slots used: **0 of 2 TACTICAL, 0 of 3 CORE** (hedge excluded).

---

## 2. Actions taken today

### ✅ SELL MDLZ — 7.988509 sh @ $62.08, realized **−$4.07 (−0.81%)**, 12 days held

Order `6aa1a3b4-2a25-4513-a02d-4f7547e07f5a`, sent 18:21:40.096Z, **filled in 103 milliseconds** at $62.08 in a single execution, zero fees — price-improved one cent above the $62.07 bid. `review_equity_order` returned `order_checks {}` beforehand: no broker alerts. Cost basis $500.00 (7.988509 @ 62.5899); proceeds $495.93.

**What fired.** The 18:03Z committed report flagged `EXIT-INTO-STRENGTH (underwater — optional)` on MDLZ at **RSI2 75.5**, with the annotation *"2d to the time stop (held 12d) — this bounce is likely the better exit price."* At decision time MDLZ traded 62.08, **+0.73% on a day SPY was −0.44% and every other name in the book was red**. That was the highest price and the highest RSI2 of the entire hold.

**What this was NOT, and the distinction matters.** It was **not** the mechanical RSI2≥70 take-profit. That authority is *profit-banking*, gated on `price > entry` (the 2026-08-26 correction), and MDLZ was underwater — so it was structurally unavailable and was never invoked. It was **not** a thesis sell either: every invalidation level in the entry plan was intact (no FY26 guidance cut, analyst complex above spot, price 5%+ above a rising 200-day). Filing it as either would misrepresent the decision. It was a **discretionary exit-into-strength**, which is what the rules call this state.

**The actual argument.** The time stop fires **2026-09-11** and is not discretionary — it sells green or red. So the only live question was *price*, never *whether*. Two facts decided it:
1. The 2026-09-02 amendment, written into both HARD RULE 5 and prompt v10, addresses exactly this state: within `TIME_STOP_WARN_DAYS` (3), *"a position about to be recycled anyway is better sold INTO a bounce than out of one."* Day 12 of 14 is inside that window.
2. **2026-09-11 is the CPI print.** The mechanical sale would have executed into a macro-conditioned tape — an unknown price two days out, versus a known one in hand at the bounce's high.

**The steelman for holding, and why it lost.** MDLZ needed only +0.79% to reach breakeven and was moving that way; two more sessions might have converted this into a proper green take-profit. Rejected because it asks the position to do in 2 sessions what it did not do in 12, *through a CPI print* — and because the green-take-profit scenario requires a **conjunction** (price up **and** RSI2 still ≥70) while RSI2 at 75.5 mean-reverts down fast. A conjunction is not the base case.

**Deviation duty discharged.** The prior instance's written plan said: *"bank on target 64.70 or an RSI2≥70 print while GREEN (an RSI2≥70 print while UNDERWATER is an optional exit-into-strength, never mandatory)."* The plan is right that this is never mandatory, and it was not treated as mandatory. What a day-0 plan cannot price is that **the optionality expires**: holding on an intact thesis buys runway only while runway exists, and the time stop removes it. Four earlier runs today (14:12Z, 15:20Z, 15:35Z, 16:45Z) held the same signal correctly, each giving the same stated reason — the bounce was *weaker* than when the plan was written (61.755 / 61.610 vs 61.855). At 62.08 that reason inverted. This run acted on the new fact, not on a re-litigation of theirs.

### ✅ GD thesis check → **INTACT**, written back to the ledger

The 14:01Z report flagged GD `REVIEW / THESIS-CHECK` on *below 200-day MA* (352.97 vs 354.66 — **0.4% below, marginal not decisive**). Full HARD RULE 7 research returned **INTACT**, and the fundamentals are *strengthening*, not breaking: Q2-26 revenue $14.09B and adj EPS $4.24; **FY2026 EPS guidance raised to $16.80-16.90**; Gulfstream revenue +15.1% on higher deliveries; Marine Systems +10.4%; a new $194.1M Mission Systems contract modification; quarterly dividend $1.59 declared. Consensus Moderate Buy, mean target ~8.9% above spot. The one negative in the record is *segment-level* — U.S. demand concerns in Combat Systems — and a single soft segment inside a raised company-level guide is not a dead thesis. Corroborating that this is sector flow rather than company-specific: **RTX prints RSI2 4.8 on the same screen**, i.e. the defense complex is oversold together.

Verdict written to `holdings.json` as `thesis_checked` so the flag stops re-firing for 30 days. **GD holds to its 2026-09-15 time stop, which is its real exit gate.**

### 🔧 Two repairs pushed today
- **`iv_history.json` key rename** (19:00Z run): the 14:02Z sweep wrote all 8 core rows under renamed ratio keys, silently breaking the series diff that the IV method depends on. Normalized — labels only, no values touched.
- **Report workflow mislabel** (13:31Z run): the schedule-backstop branch mislabelled late fires, so a late cron could write a mid-session scan into `latest_morning.md` as the day's *morning* report.

---

## 3. Candidates considered and SKIPPED

### Equities — one open slot, $1,759.59 deployable, and still no entry

The RSI(2) screen produced a **17-name cohort**, and it is not seventeen ideas — **it is one trade**: a rate-and-defensives repricing. That is the whole reason for the skip, and it was re-measured live this run rather than inherited.

**Every one of the 14 cohort names I quoted at 19:16Z is red on the day:**

| | | | |
|---|---|---|---|
| DLTR **−3.64%** | ABNB −2.79% | PATH −2.43% | TGT −2.09% |
| BLK −1.60% | VRTX −1.50% | T −1.46% | SBUX −1.44% |
| UNP −1.13% | AMGN −0.48% | MA −0.45% | WBD −0.44% |
| BMY −0.37% | CL −0.32% | | |

**14 of 14.** This is the third consecutive session the cohort has extended rather than reverted, and DLTR — graded the *cleanest* name on the list yesterday — is down another 3.64% on top of 09-08's −5.34%. **A mean-reversion cohort that falls every session is not yet mean-reverting.** Buying it now is buying the knife *before* the catalyst that is cutting it, with **PPI tomorrow and CPI Friday**.

Specific grades carried and re-checked:
- **DLTR — B.** No company-specific bad news; Barclays raised to $160 Overweight on 09-04, mean PT $137.33 vs spot $119.53 (+14.9% implied). But the move is the XRT retail de-rating, i.e. squarely the rate shock. Best name on the list and **still not A**.
- **AMGN — C.** Not a dip. Novartis pelacarsen Phase 3 missed its primary endpoint; the read-across hit Amgen's olpasiran and BMO cut to Market Perform. A live scientific dispute is not a mean-reversion setup.
- **ABNB — B.** Baird raised PT $175→$200, but consumer discretionary is the epicentre of the repricing.
- **SBUX, CL, MA, VRTX, BMY, T, UNP, BLK, TGT, WBD, PATH — B/C.** All the same factor as each other *and* as the three names already held. Adding a fourth correlated position is concentration without selection.
- **MMM / LLY — HELD**, not re-entered. HARD RULE 3 (FOUR LAWS #3) forbids adding to a loser without Ryan's explicit approval.

**Why this is a decline and not queuing.** Deployable ($1,759.59) far exceeds the ~$600 minimum entry, so the rotation gate does not bind and the ordinary branch applies: *is there an A-grade setup?* There is not, and the policy states plainly that **saying so is the correct output**. A B-grade gets **no** position, not a small one — and at a 30% cap the compliant size here would be **$1,173.12**, i.e. the only entry available would be one at maximum single-name concentration, into the epicentre of a live repricing, two days before CPI. That is precisely the trade the concentration policy exists to prevent: *fewer must mean more selective, never merely bigger.*

The live `_cash_hold` (set 09-08, **expiry 2026-09-14**) covers this with a named opportunity, checkable date triggers (PPI 09-10, CPI 09-11) and a hard expiry. It stands on its own written terms — **not extended, not re-argued, and not converted into a floor.**

### Options — both tracks hunted, neither armed

- **TACTICAL: no arm, and the bar is regime, not the filter.** One genuine structural level remains live — the **QQQ 20-day SMA at 717.385**, with spot 716.45, i.e. **0.935 below it and drifting away** rather than coiling on it. No break is in progress, so nothing to confirm. Independently, the **2026-08-26 capstone bars TACTICAL breakout scalps into an unresolved scheduled catalyst**, and PPI (Thu) plus CPI (Fri) are exactly that. That finding was earned the hard way — five failed breaks across two sessions, with setup quality *rising* while the outcome stayed identical, which is what established that the regime and not the measurement was the dominant variable.
- **CORE: no candidate.** No thesis presented. The equity report's RSI2 names have been measured twice at roughly zero options-tradeability (12-52% of mid), and a cheap liquid vehicle supplies no thesis in any case. IV context from today's own sweep: SPY .1299, QQQ .1895, NVDA .3451, AMD .5329, TSM .3353, AVGO .3871, MSFT .2555, TSLA .4265 — nothing flagged materially cheap against realized on the pair-read.
- **No spread spec was handed to Ryan today** (multi-leg tickets remain unplaceable through the agentic API; legging is authorized but requires a thesis, and there wasn't one).

---

## 4. Sleeve state

| | |
|---|---|
| **Total account value** | **$3,910.39** |
| Cash | $1,955.11 |
| `unleveraged_buying_power` | **$1,955.11** — equal to `buying_power` and to cash, so **no margin is being extended.** FOUR LAWS #4 clean. |
| Operational reserve (5% of total) | **$195.52** (recomputed this run, never hard-coded) |
| **Deployable** | **$1,759.59** |
| Per-name cap (30% of total) | $1,173.12 — **binding** on any single entry |
| Equity value | $1,419.28 (3 swings) |
| Options premium at risk | $749.00 cost / $535.00 mark — **hedge only**; $0 TACTICAL, $0 CORE |
| **Realized P/L today — options** | **$0.00** vs the −$400 cap. Broker-confirmed: `get_option_orders(09-09)` empty. |
| **Realized P/L today — equities** | **−$4.07** on 1 closing trade (the MDLZ exit), broker-confirmed via `get_realized_pnl`. |
| Options entry throttle | **0 of 8** used |
| Equity entry throttle | **0 of 3** used *(an exit is never an entry; exits are never throttled)* |
| Equity slots | **3 of the 3-4 target** — one open |

**Weekly calibration:** run and complete for this week at 10:25Z on 09-08 (Tuesday was the week's first trading day, Monday being Labor Day). **Verdict on both books: NO CHANGE, no parameter altered, nothing escalated.** Equities n=55, hit 69.1%, payoff 0.97, breakeven 50.8%, **margin +18.3 pts**, expectancy +$4.82/trade — but **only 2 of those 55 closes happened under the current parameters**, so the in-regime gate blocked any tuning, exactly as designed. Options n=17, hit 52.9% against a **53.3% breakeven — margin −0.3 pts**; the +$90 net is carried entirely by QQQ +$226 and WULF +$208, and stripping those two leaves the other 15 closes at about −$344. Below `MIN_TRADES_FOR_ACTION` either way: report, do not adjust.

---

## 5. Tomorrow's watchpoints

1. **🔴 LLY TIME STOP FIRES 2026-09-10 — day 14 of 14.** It sells **green or red**, and it is the book's only mechanical loss discipline. At today's mark that is a ~−$27 realization on a −5.38% position. **This takes the equity book to 2 concurrent swings, below the 3-4 target band.** Note for the run that handles it: the exit-into-strength logic that governed MDLZ applies to LLY too — LLY was the one green name today (+0.16%), so if a bounce is offered before the stop date, taking it is preferable to selling out of one.
2. **PPI, Thursday 2026-09-10.** First of the two macro prints the cash hold is waiting on.
3. **CPI, Friday 2026-09-11, 08:30 ET** (headline seen 3.4%, core 2.4%) — the trigger the entire 17-name cohort is being deferred past.
4. **`_cash_hold` expires 2026-09-14.** On that date it **dissolves automatically** and the capital returns to normal full deployment, whatever CPI printed and whether or not a better setup appeared. No run may extend it without a *new* named catalyst and a *new* expiry.
5. **Re-grade the RSI2 cohort post-CPI, from scratch, on the post-event numbers.** Do not carry today's grades forward: a deferral is never a thesis judgement, and a gap-up is not a gift to a mean-reversion setup — it can just as easily consume the edge.
6. **Earnings in the window:** ORCL and ADBE Thu 09-10 pm, RH 09-10 pm, KR Fri 09-11 am. **None of the three held swings reports inside 21 days** — verified against `get_earnings_calendar`, not assumed. Standing caveat: the calendar degrades to empty on API failure, so absence is not proof — re-check any name actually being bought.
7. **QQQ 20-day SMA 717.385** remains the only live structural level for TACTICAL. Any fire must clear **both** denominator corrections (trailing-local *and* the session's own bucket rate) plus the feed-hole reconciliation — and the regime bar stands until CPI resolves.

---

*Positions: 3 equity swings + 1 hedge. Actions: 1 (MDLZ exit, −$4.07). Entries: 0 of 3 equity, 0 of 8 options. Reconciliation: zero drift, broker-read first. Next mechanical event: LLY time stop, 2026-09-10.*
